Do Inpatients Receive Risk-Based Prophylactic Treatment for Thrombotic Events?

Armin NemaniConstantin von Zur MühlenFriederike SteffenJohannes SchulteChristoph BodeMarvin Krohn-Grimberghe

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2021)

The overall rate of VTE prophylaxis was high in both patient populations. Significant more low-risk cardiology compared to gastroenterology patients received drug-based prophylaxis. Furthermore, crucial discrepancies were found in the way individual patients would be classified based on PPS and IMPROVE Score. Finally, not the risk category but the length of hospital stay was best at predicting which patient received prophylaxis.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
prognostic factors
case report
emergency department
adverse drug
electronic health record